S

Stephen D. Wiviott

Thrombolysis in Myocardial Infarction Study Group

ORCID: 0000-0002-4922-9880

112 papers and 14.5k citations.

PubIndex Score95Top 5%How it's scored

112Publications

14.5kTotal Citations

First senior author: 2007

Top publicationsby citations

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Marc S. Sabatine, Terje R. Pedersen, Robert P. Giugliano et al.|New England Journal of Medicine|2017

Cited by 6k

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

Colin Baigent, Faı̈ez Zannad, Stefan D. Anker et al.|The Lancet|2022

Cited by 969

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

Ofri Mosenzon, Itamar Raz, Stephen D. Wiviott et al.|The Lancet Diabetes & Endocrinology|2019

Cited by 673

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

Steven Grinspoon, Pamela S. Douglas, Kathleen V. Fitch et al.|New England Journal of Medicine|2023

Cited by 447

Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

Ellen M. Apperloo, Hiddo J.L. Heerspink, Brendon L. Neuen et al.|The Lancet Diabetes & Endocrinology|2024

Cited by 135

Indexing the rest of 112 publications…